Suppr超能文献

溃疡性结肠炎中的抗中性粒细胞胞浆抗体(ANCA):抗组织蛋白酶G和一种新型抗体与难治型相关。

Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type.

作者信息

Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, Nakao K

机构信息

Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan.

出版信息

Clin Exp Immunol. 1996 Jul;105(1):120-4. doi: 10.1046/j.1365-2249.1996.d01-724.x.

Abstract

We analysed the clinical significance of ANCA in patients with ulcerative colitis. On either an indirect immunofluorescence assay or an ELISA with fixed neutrophils, 71% (25/35) of the patients were positive for ANCA. However, only half of them reacted with either cathepsin G or lactoferrin. Western blot assays revealed positive bands in 40% (10/25) of the antibody-positive patients. The sizes of the bands detected were approximately 58, 47, 44, 40, and 28 kD. No significant correlation was found between the ANCA positivity and various variables, i.e. disease activity, extent of lesion, or treatment of the disease. The anti-cathepsin G and 28-kD positivity, however, significantly correlated with a refractory type of ulcerative colitis.

摘要

我们分析了抗中性粒细胞胞浆抗体(ANCA)在溃疡性结肠炎患者中的临床意义。在间接免疫荧光试验或使用固定中性粒细胞的酶联免疫吸附测定(ELISA)中,71%(25/35)的患者ANCA呈阳性。然而,其中只有一半与组织蛋白酶G或乳铁蛋白发生反应。蛋白质印迹分析显示,40%(10/25)的抗体阳性患者出现阳性条带。检测到的条带大小约为58、47、44、40和28 kDa。未发现ANCA阳性与各种变量之间存在显著相关性,即疾病活动度、病变范围或疾病治疗情况。然而,抗组织蛋白酶G和28-kDa阳性与难治性溃疡性结肠炎显著相关。

相似文献

6
Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis.
J Clin Pathol. 1994 Mar;47(3):257-62. doi: 10.1136/jcp.47.3.257.
7
Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis.
J Gastroenterol. 2000;35(9):682-9. doi: 10.1007/s005350070047.
10
Antineutrophil cytoplasmic autoantibodies antigen specificity.
Am J Kidney Dis. 1991 Aug;18(2):159-63. doi: 10.1016/s0272-6386(12)80873-0.

引用本文的文献

1
Current and Emerging Autoantibodies in Ulcerative Colitis.
Eur J Immunol. 2025 Aug;55(8):e51721. doi: 10.1002/eji.202451721.
2
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
4
Targeting cathepsin G in myeloid leukemia.
Oncoimmunology. 2013 Apr 1;2(4):e23442. doi: 10.4161/onci.23442.
5
A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.
Clin Cancer Res. 2013 Jan 1;19(1):247-57. doi: 10.1158/1078-0432.CCR-12-2753. Epub 2012 Nov 12.
6
Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.
Wien Klin Wochenschr. 2010 May;122 Suppl 2:19-25. doi: 10.1007/s00508-010-1344-y.
8
Defensins- and cathepsin G-ANCA in systemic lupus erythematosus.
Rheumatol Int. 2006 Dec;27(2):147-52. doi: 10.1007/s00296-006-0173-9. Epub 2006 Aug 10.
10
Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?
Clin Exp Immunol. 1999 May;116(2):206-13. doi: 10.1046/j.1365-2249.1999.00905.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验